ACURATE neo™
Aortic Valve System
Self-expanding & Supra-annular
Valve Measurements & Sizing
Unique Phased Top-down Deployment
Physician experience
"The advantage of the ACURATE neo [valve] is the very quick and intuitive implantation process, and it’s also the convincing clinical data."
Prof. Dr. Tanja Rudolph
Köln, Germany
Delivery Systems
ACURATE neo Transfemoral Delivery System
Flexible and intuitive valve delivery and positioning designed to minimize complications and improve procedural efficiency1,2
Product Specification
| Access Route | Transfemoral |
| Deployment Procedure | Phased, Top-Down Deployment |
| Guidewire Compatibility | 0.035" (0.89 mm) |
| Usable Length | 109 cm |
| Valve Compatibility | For use with all ACURATE neo Aortic Bioprosthesis (S, M, L) |
| Introducer Compatibility | 14F (≥ 5.5 mm) with iSLEEVE Expandable Introducer Set |
| Use | Single Use |
| Sterilization | Gamma Irradiation Process |
| Carton Size (Delivery System Only) | 1,720 mm × 390 mm × 89 mm |
| Indications for Use | The ACURATE TF Transfemoral Delivery System with the ACURATE neo Aortic Bioprosthesis are indicated to improve valve function for symptomatic patients with severe calcific aortic stenosis (mean aortic gradient > 40 mmHg or peak jet velocity > 4.0 m/s or aortic valve area < 1.0 cm²) with high risk for conventional surgical aortic valve replacement (sAVR). See instructions for use (IFU) for details. |
ACURATE neo Transapical Delivery System
The only self-expanding, supra-annular valve for transapical TAVI. Low-profile access with straightforward valve delivery and positioning minimizes complications and improves procedural efficiency3
Product Specification
| Access Route | Transapical |
| Deployment Procedure | Phased, Top-Down Deployment |
| Guidewire Compatibility | 0.035" (0.89 mm) |
| Usable Length | 32 cm |
| Valve Compatibility | For use with all ACURATE neo Bioprosthesis (S, M, L) |
| Access | Sheathless |
| Shaft Outer Diameter | 19F |
| Valve Housing Outer Diameter | 22F |
| Use | Single Use |
| Sterilization | Gamma Irradiation Process |
| Carton Size (Delivery System Only) | 1,130 mm × 390 mm × 89 mm |
| Indications for Use | The ACURATE neo TA Transapical Delivery System with the ACURATE neo Aortic Bioprosthesis are indicated to improve valve function for symptomatic patients with severe calcific aorticstenosis (mean aortic gradient > 40 mmHg or peak jet velocity > 4.0 m/s or aortic valve area < 1.0 cm²) with high risk for conventional surgical aortic valve replacement (sAVR). See instructions for use (IFU) for details. |
Clinical case
A clinical case performed using the ACURATE neo Aortic Valve and Transapical Delivery System.
Prof. Dr. David Holzhey
Herzzentrum Leipzig, Germany